发明名称 |
HEPATITIS C INHIBITOR COMPOUNDS |
摘要 |
Compounds of Formula (I): wherein B, R3, L0, L1, R2, Rc and R1 are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection. In particular, the present invention provides novel peptide analogs, pharmaceutical compositions containing such analogs, and uses of these analogs in the treatment of HCV infection
|
申请公布号 |
CA2737958(A1) |
申请公布日期 |
2010.04.01 |
申请号 |
CA20092737958 |
申请日期 |
2009.09.14 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
O'MEARA, JEFFREY;BORDELEAU, JOSEE;GORYS, VIDA;LEBLANC, MELISSA;LENHARDT, KIRSTEN;LLINAS-BRUNET, MONTSE;PARISIEN, MATHIEU;POUPART, MARC-ANDRE;LENHARDT, KIRSTEN |
分类号 |
C07D417/14;A61K31/4709;A61K31/506;A61P31/14 |
主分类号 |
C07D417/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|